05/12/2025
9:44 AM | Myriad Genetics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
05/06/2025
7:48 PM | Myriad Genetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/01/2025
3:24 PM | Myriad Genetics (Issuer)
Raha Samraat S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
3:27 PM | Myriad Genetics (Issuer)
Verratti Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2025
4:32 PM | DIAZ PAUL J (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
3:06 PM | Myriad Genetics (Filer)
| Form DEF 14A | |
04/09/2025
3:08 PM | Myriad Genetics (Filer)
| Form DEFA14A | |
03/25/2025
3:16 PM | DIAZ PAUL J (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2025
3:16 PM | Myriad Genetics (Issuer)
Verratti Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2025
3:16 PM | Muzzey Dale (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2025
3:17 PM | Haas Kevin Richard (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for MYGN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Myriad Genetics and its competitors with MarketBeat's FREE daily newsletter. |
03/25/2025
3:17 PM | Munk Natalie (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2025
3:17 PM | Ancona Margaret (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
3:19 PM | DIAZ PAUL J (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
3:19 PM | Myriad Genetics (Issuer)
Raha Samraat S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
3:19 PM | Leffler Scott J. (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
3:19 PM | Myriad Genetics (Issuer)
Verratti Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:31 PM | DIAZ PAUL J (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:31 PM | Myriad Genetics (Issuer)
Verratti Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:31 PM | Muzzey Dale (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:31 PM | Haas Kevin Richard (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:31 PM | Ancona Margaret (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:32 PM | Munk Natalie (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
3:36 PM | Myriad Genetics (Issuer)
Solaiman Shereen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
3:05 PM | Myriad Genetics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/26/2025
3:21 PM | Haas Kevin Richard (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
7:32 AM | Camber Capital Management LP (Filed by)
Myriad Genetics (Subject)
| Form SCHEDULE 13G/A | |
02/10/2025
9:25 AM | Myriad Genetics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
01/30/2025
3:23 PM | Leffler Scott J. (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
7:39 AM | Myriad Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2024
3:19 PM | Myriad Genetics (Issuer)
Raha Samraat S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
3:36 PM | Davis Mark Steven (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
3:51 PM | Davis Mark Steven (Reporting)
Myriad Genetics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/02/2024
3:17 PM | Myriad Genetics (Issuer)
Raha Samraat S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
3:42 PM | Myriad Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
7:18 AM | Myriad Genetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/11/2024
4:23 PM | DIAZ PAUL J (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
9:35 AM | DIAZ PAUL J (Reporting)
Myriad Genetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/10/2024
3:31 PM | Haas Kevin Richard (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2024
3:33 PM | Muzzey Dale (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2024
3:36 PM | Myriad Genetics (Issuer)
Verratti Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad) So, unless you’ve been living under a rock, you probably saw the news…
Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯
We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer. 🎯 Click here to watch the video and get the free ticker XGPT just flagged. |
10/09/2024
5:11 AM | Myriad Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
3:15 PM | Munk Natalie (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
3:17 PM | Ancona Margaret (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
3:21 PM | Myriad Genetics (Issuer)
Verratti Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
1:30 PM | Ancona Margaret (Reporting)
Myriad Genetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
3:09 PM | Muzzey Dale (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
3:11 PM | DIAZ PAUL J (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
2:26 PM | Muzzey Dale (Reporting)
Myriad Genetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
9:05 AM | DIAZ PAUL J (Reporting)
Myriad Genetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024
4:48 PM | Dreismann Heinrich (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
1:52 PM | Dreismann Heinrich (Reporting)
Myriad Genetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
6:51 PM | Fox Jennifer Lynne (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
6:38 PM | Myriad Genetics (Issuer)
Reitan Colleen F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
7:43 PM | Myriad Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2024
3:33 PM | Fox Jennifer Lynne (Reporting)
Myriad Genetics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/03/2024
9:11 AM | Myriad Genetics (Subject)
Reitan Colleen F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
3:48 PM | Munk Natalie (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
3:16 PM | Ancona Margaret (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:38 PM | Kumar Rashmi (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
1:46 PM | Kumar Rashmi (Reporting)
Myriad Genetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2024
3:27 PM | DIAZ PAUL J (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
7:22 AM | Myriad Genetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/04/2024
4:57 PM | Myriad Genetics (Issuer)
SPIEGELMAN DANIEL K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
9:32 AM | Myriad Genetics (Subject)
SPIEGELMAN DANIEL K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
12:48 PM | Myriad Genetics (Subject)
SPIEGELMAN DANIEL K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
